Skip to main content Back to Top


Quinidine Gluconate Injection

Products Affected - Description

    • Quinidine gluconate injection, Lilly USA, LLC, 80 mg/mL, 10 mL vial, 1 count, NDC 00002-1407-0

Reason for the Shortage

    • Lilly USA is the sole supplier of quinidine gluconate injection and is discontinuing the manufacture of the product.

Available Products

    • There is insufficient supply for usual ordering.

Estimated Resupply Dates

    • Lilly USA has quinidine gluconate 80 mg/mL 10 mL vials available with short expiry dating of March 2019. They will not be manufacturing more product once currently available product is gone.

Implications for Patient Care

    • CDC and FDA are working to ensure adequate treatment options are available for patients.


Created January 11, 2019 by Anthony Trovato, Pharmacy Resident. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.


Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins